A PROOF-OF-CONCEPT CLINICAL STUDY, TO ASSESS THE EFFECT OF GED-0507-34-Levo 80 mg Tablets IN INDUCTION OF REMISSION OF ACTIVE ULCERATIVE COLITIS [STUDIO CLINICO PER LA VERIFICA DELL`EFFETTO DI GED-0507-34-Levo COMPRESSE 80 MG NELL`INDUZIONE ALLA REMISSIONE DI COLITE ULCEROSA IN FASE ATTIVA]

Trial Profile

A PROOF-OF-CONCEPT CLINICAL STUDY, TO ASSESS THE EFFECT OF GED-0507-34-Levo 80 mg Tablets IN INDUCTION OF REMISSION OF ACTIVE ULCERATIVE COLITIS [STUDIO CLINICO PER LA VERIFICA DELL`EFFETTO DI GED-0507-34-Levo COMPRESSE 80 MG NELL`INDUZIONE ALLA REMISSIONE DI COLITE ULCEROSA IN FASE ATTIVA]

Completed
Phase of Trial: Phase II

Latest Information Update: 03 Feb 2014

At a glance

  • Drugs GED 0507 34 Levo (Primary)
  • Indications Ulcerative colitis
  • Focus Therapeutic Use
  • Sponsors Giuliani
  • Most Recent Events

    • 03 Feb 2014 Status changed from recruiting to completed according to European Clinical Trials Database record.
    • 15 Mar 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top